Soins Infirmiers et Développement Communautaire (SIDC)

Email

racheladaime@hotmail.com

Phone

T: +96 114 91705

Web

www.sidc-lebanon.org

Address

“Youssef Karam Street, Daou Building, Fi, “Sin el Fil, Al Matn, First Floor”, Beirut 55391 55391 Lebanon
About Soins Infirmiers et Développement Communautaire (SIDC)

SIDC Vision

SIDC’s vision is to become the strength behind an adequately served, healthy, and empowered community by providing the right services and guaranteeing a better quality of life for youth and key affected populations in Lebanon.

 

SIDC's Mission

SIDC’s mission is to develop social solidarity by reinforcing healthy behaviours in Lebanon through prevention, harm reduction policies, advocacy, and psychosocial services for our target populations (drug users, people living with HIV, vulnerable and stigmatised people).

 

Our objectives, which go hand-in-hand with the needs of the community and are based on the evaluations and observations executed by our field-working teams, are as follows:

– To inform, prevent, and reduce the number of infections related to HIV, STIs, and risky behaviours, through the awareness of our youth, Drug Users, Female and Male Sex Workers, Men who have Sex with Men, and society on the whole.

– To improve, on the longer run, the living conditions of people made vulnerable by stigma and discrimination in our society by providing them with a surrounding where their dignity and rights are preserved.

– To develop our diverse programmes (HIV and addiction programmes) in order to respond to a community that is increasingly touched by HIV, STIs and addictive behaviours.

– To involve the community actors and policymakers in order to change the laws and prejudices that govern our country.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close